In a regulatory filing, Tandem Diabetes disclosed that on June 19, the Board of Directors of Tandem approved the appointment of Jean-Claude Kyrillos as Executive Vice President, COO, effective June 21, 2024. Before joining the company, Kyrillos served in operating company president roles at Envista Holdings from February 2020 to June 2023, most recently as President of Diagnostics and Digital Solutions.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TNDM:
- Tandem Diabetes appoints Kyrillos as EVP, COO
- Tandem Diabetes extends development agreement with DexCom
- Tandem Diabetes price target raised to $58 from $47 at Oppenheimer
- Tandem Diabetes’ (NASDAQ:TNDM) Stock Surges, But Faces fierce Competition
- PayPal upgraded, UiPath downgraded: Wall Street’s top analyst calls